Affiliation:
1. Department of Molecular Microbiology, VIB, KU Leuven, Leuven, Belgium
2. Laboratory of Molecular Cell Biology, KU Leuven, Leuven, Belgium
Abstract
ABSTRACT
Candida glabrata
is reported as the second most prevalent human opportunistic fungal pathogen in the United States. Over the last decades, its incidence increased, whereas that of
Candida albicans
decreased slightly. One of the main reasons for this shift is attributed to the inherent tolerance of
C. glabrata
toward the commonly used azole antifungal drugs. Despite a close phylogenetic distance to
Saccharomyces cerevisiae
, homologous recombination works with poor efficiency in
C. glabrata
compared to baker's yeast, in fact limiting targeted genetic alterations of the pathogen's genome. It has been shown that nonhomologous DNA end joining is dominant over specific gene targeting in
C. glabrata
. To improve the homologous recombination efficiency, we have generated a strain in which the
LIG4
gene has been deleted, which resulted in a significant increase in correct gene targeting. The very specific function of Lig4 in mediating nonhomologous end joining is the reason for the absence of clear side effects, some of which affect the
ku80
mutant, another mutant with reduced nonhomologous end joining. We also generated a
LIG4
reintegration cassette. Our results show that the
lig4
mutant strain may be a valuable tool for the
C. glabrata
research community.
Publisher
American Society for Microbiology
Subject
Molecular Biology,General Medicine,Microbiology
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献